Immunogenetics: A Molecular and Clinical Overview: Immunogenetic Factors and Signaling Pathways in Recurrent Miscarriage, Volume Four provides an overview of the scientific knowledge, achievements, and findings in the field of immunogenetics of recurrent pregnancy loss. With a strong focus on the role immune cells can play in recurrent pregnancy loss, the book also examines immune therapeutic aspects. In seventeen chapters, the book describes the roles of several different signaling pathways and the role of JLA and microRNAs in recurrent pregnancy loss. Several chapters are dedicated to the role autoimmune antibodies play in recurrent pregnancy loss. This book is a valuable resource for health professionals, scientists, researchers, and all those who wish to broaden their knowledge in the allied field.
1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iv 6. Contributors - p. xv 7. Preface - p. xix 8. Chapter 1. Role of CD4+ helper T cell in recurrent pregnancy loss - p. 1 9. Chapter 2. Role of natural killer and innate lymphoid cells in recurrent pregnancy loss - p. 25 10. Chapter 3. Role of T regulatory in recurrent pregnancy loss - p. 41 11. Chapter 4. Role of CD8+ cytotoxic T cells in recurrent pregnancy loss - p. 55 12. Chapter 5. Role of B cells, macrophages, and dendritic cells in recurrent pregnancy loss - p. 69 13. Chapter 6. Clinical outcome of low molecular weight heparin (LMWH) and aspirin therapy in recurrent pregnancy loss patients - p. 85 14. Chapter 7. Clinical outcome of intravenous immunoglobulin (IVIg) therapy in recurrent pregnancy loss patients - p. 105 15. Chapter 8. Vitamin D3 therapy and clinical outcome in recurrent pregnancy loss patients - p. 119 16. Chapter 9. Efficacy of intralipid infusion therapy in the treatment of recurrent pregnancy loss patients - p. 147 17. Chapter 10. Therapeutic potential of cyclosporine in recurrent pregnancy loss - p. 159 18. Chapter 11. Progesterone therapy and clinical outcome in recurrent pregnancy loss patients - p. 177 19. Chapter 12. Efficacy of granulocyte-colony stimulating factor (G-CSF) therapy in patients with recurrent pregnancy loss - p. 193 20. Chapter 13. Lymphocyte immunotherapy and clinical outcome in recurrent pregnancy loss patients - p. 215 21. Chapter 14. Tnf-α inhibition and treatment of recurrent pregnancy loss - p. 239 22. Chapter 15. Genetic counseling and clinical pregnancy outcome: A way forward - p. 259 23. Chapter 16. Importance of evidence-based medical treatments for recurrent pregnancy loss - p. 279 24. Chapter 17. Evidence-based new developments in reproductive immunogenetics and future perspectives - p. 287 25. Index - p. 299
Immunogenetics: A Molecular and Clinical Overview: Immunogenetic Factors and Signaling Pathways in Recurrent Miscarriage, Volume Four provides an overview of the scientific knowledge, achievements, and findings in the field of immunogenetics of recurrent pregnancy loss. With a strong focus on the role immune cells can play in recurrent pregnancy loss, the book also examines immune therapeutic aspects. In seventeen chapters, the book describes the roles of several different signaling pathways and the role of JLA and microRNAs in recurrent pregnancy loss. Several chapters are dedicated to the role autoimmune antibodies play in recurrent pregnancy loss. This book is a valuable resource for health professionals, scientists, researchers, and all those who wish to broaden their knowledge in the allied field.
1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iv 6. Contributors - p. xv 7. Preface - p. xix 8. Chapter 1. Role of CD4+ helper T cell in recurrent pregnancy loss - p. 1 9. Chapter 2. Role of natural killer and innate lymphoid cells in recurrent pregnancy loss - p. 25 10. Chapter 3. Role of T regulatory in recurrent pregnancy loss - p. 41 11. Chapter 4. Role of CD8+ cytotoxic T cells in recurrent pregnancy loss - p. 55 12. Chapter 5. Role of B cells, macrophages, and dendritic cells in recurrent pregnancy loss - p. 69 13. Chapter 6. Clinical outcome of low molecular weight heparin (LMWH) and aspirin therapy in recurrent pregnancy loss patients - p. 85 14. Chapter 7. Clinical outcome of intravenous immunoglobulin (IVIg) therapy in recurrent pregnancy loss patients - p. 105 15. Chapter 8. Vitamin D3 therapy and clinical outcome in recurrent pregnancy loss patients - p. 119 16. Chapter 9. Efficacy of intralipid infusion therapy in the treatment of recurrent pregnancy loss patients - p. 147 17. Chapter 10. Therapeutic potential of cyclosporine in recurrent pregnancy loss - p. 159 18. Chapter 11. Progesterone therapy and clinical outcome in recurrent pregnancy loss patients - p. 177 19. Chapter 12. Efficacy of granulocyte-colony stimulating factor (G-CSF) therapy in patients with recurrent pregnancy loss - p. 193 20. Chapter 13. Lymphocyte immunotherapy and clinical outcome in recurrent pregnancy loss patients - p. 215 21. Chapter 14. Tnf-α inhibition and treatment of recurrent pregnancy loss - p. 239 22. Chapter 15. Genetic counseling and clinical pregnancy outcome: A way forward - p. 259 23. Chapter 16. Importance of evidence-based medical treatments for recurrent pregnancy loss - p. 279 24. Chapter 17. Evidence-based new developments in reproductive immunogenetics and future perspectives - p. 287 25. Index - p. 299
